Search - tctmd.com

Displaying 281 - 300 of 457

Sort: Relevancy | Date

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News EuroPCR 2019

Newer-Generation MitraClip XTR Shows Promise, but Beware the Learning Curve

Shelley Wood

May 27, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Conference News EuroPCR 2019

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Michael O'Riordan

May 22, 2019

News Industry News

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

May 14, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

Shelley Wood

May 01, 2019

News Industry News

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

May 01, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Industry News

Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

March 05, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

Advertisement

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

TAVR Operators: Can One Do It All or Are Two Still Justified?

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Newer-Generation MitraClip XTR Shows Promise, but Beware the Learning Curve

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

TCTMD’s Top 10 Most Popular Stories for April 2019

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content